Evidence map›Paper›PMID 35589002›Full record

ArticleCancer letters2022

Breast cancer extracellular vesicles-derived miR-1290 activates astrocytes in the brain metastatic microenvironment via the FOXA2→CNTF axis to promote progression of brain metastases.

Sherona R Sirkisoon, Grace L Wong, Noah R Aguayo, Daniel L Doheny, Dongqin Zhu, Angelina T Regua, Austin Arrigo, Sara G Manore, Calvin Wagner, Alexandra Thomas and 5 more

Open access · greenAbstract read
In one paragraph

Article in Cancer letters, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Mucin 5AC Promotes Breast Cancer Brain Metastasis through cMET/CD44v6.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Sherona R SirkisoonDepartment of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Grace L WongDepartment of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Noah R AguayoDepartment of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Daniel L DohenyDepartment of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Dongqin ZhuDepartment of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Angelina T ReguaDepartment of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Austin ArrigoDepartment of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Sara G ManoreDepartment of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Calvin WagnerDepartment of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Alexandra ThomasDepartment of Hematology and Oncology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA; Breast Cancer Center of Excellence, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA; Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Ravi SinghDepartment of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Fei XingDepartment of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA; Breast Cancer Center of Excellence, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA; Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Guangxu JinDepartment of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Kounosuke WatabeDepartment of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA; Breast Cancer Center of Excellence, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA; Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Hui-Wen LoDepartment of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA; Breast Cancer Center of Excellence, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA; Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA. Electronic address: hlo@wakehealth.edu.
Wake Forest University · USAtrium Health Wake Forest Baptist · US

Funding

Tumor Tissue CoreP30CA012197 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Ruben A. Mesa · 1985 to 2026
$55.4M
Truncated GLI1 In GlioblastomaR01NS087169 · NINDS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI LO, HUI-WEN · 2014 to 2018
$2.1M
Roles of tGLI1 and microRNA Network in Breast Cancer Brain MetastasisR01CA228137 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI LO, HUI-WEN, WATABE, KOUNOSUKE · 2020 to 2025
$2.1M
Development of a novel therapeutic agent that exploits specific vulnerabilities in claudin low breast cancerR01CA207222 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI SINGH, RAVI N · 2017 to 2021
$1.7M
Translational Oncology Training ProgramT32CA247819 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI PARDEE, TIMOTHY SEBASTIAN, WATABE, KOUNOSUKE · 2020 to 2024
$1.4M
NCI NIH HHS P30 CA012197NCI NIH HHS R01 CA207222NCI NIH HHS R01 CA228137NCI NIH HHS T32 CA247819NINDS NIH HHS R01 NS087169
6 · The paper itself

Abstract

Mechanisms underlying breast cancer brain metastasis (BCBM) are still unclear. In this study, we observed that extracellular vesicles (EVs) secreted from breast cancer cells with increased expression of tGLI1, a BCBM-promoting transcription factor, strongly activated astrocytes. EV-derived microRNA/miRNA microarray revealed tGLI1-positive breast cancer cells highly secreted miR-1290 and miR-1246 encapsulated in EVs. Genetic knockin/knockout studies established a direct link between tGLI1 and both miRNAs. Datamining and analysis of patient samples revealed that BCBM patients had more circulating EV-miRs-1290/1246 than those without metastasis. Ectopic expression of miR-1290 or miR-1246 strongly activated astrocytes whereas their inhibitors abrogated the effect. Conditioned media from miR-1290- or miR-1246-overexpressing astrocytes promoted mammospheres. Furthermore, miRs-1290/1246 suppressed expression of FOXA2 transcription repressor, leading to CNTF cytokine secretion and subsequent activation of astrocytes. Finally, we conducted a mouse study to demonstrate that astrocytes overexpressing miR-1290, but not miR-1246, enhanced intracranial colonization and growth of breast cancer cells. Collectively, our findings demonstrate, for the first time, that breast cancer EV-derived miR-1290 and miR-1246 activate astrocytes in the brain metastatic microenvironment and that EV-derived miR-1290 promotes progression of brain metastases through the novel EV-miR-1290→FOXA2→CNTF signaling axis.

Indexed as

Brain NeoplasmsBreast NeoplasmsCiliary Neurotrophic FactorExtracellular VesiclesHepatocyte Nuclear Factor 3-betaMicroRNAsAnimalsAstrocytesBrainCell Line, TumorFemaleHumansMiceTranscription FactorsTumor MicroenvironmentCiliary Neurotrophic FactorFOXA2 protein, humanHepatocyte Nuclear Factor 3-betaMicroRNAsMIRN1290 microRNA, humanTranscription FactorsBrain microenvironmentBreast cancer brain metastasisExtracellular vesiclesmicroRNAstGLI1

Identifiers

PMID35589002
PMCPMC9387054
OpenAlexW4280552294

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.